Dr. David King: Non-Compressible Hemorrhages and ResQFoam

The Jake Fisher Medical Podcast

Dr. David King is an Acute Care Surgeon at Massachusetts General Hospital Trauma Center. He received his MD, completed his residency and fellowship at the University of Miami along with a residency stop at Beth Israel Deaconess Medical Center. Dr. King was an U.S. Army Lieutenant and combat surgeon before Mass General. Dr. King is the principal investigator in the upcoming REVIVE trial for ResQFoam. ResQFoam is a hemostatic agent that applies pressure to the internal active bleeding site. Tune in for our discussion on acute care treatment and how ResQFoam can be a vital treatment in the future.